Patent details

Basic Information

Publication number:

EP2988751

PCT Application Number:

US2014035454

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP147885461

PCT Publication Number:

WO2014176501

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ORAL CEFEPIME COMPOSITIONS AND USES THEREOF

French Title of Invention:

COMPOSITIONS DE CÉFÉPIME ORALES ET UTILISATIONS CORRESPONDANTES

German Title of Invention:

ORALE CEFEPIMZUSAMMENSETZUNGEN UND VERWENDUNGEN DAVON

SPC Number:

Dates

Filing date:

25/04/2014

Grant date:

20/02/2019

EP Publication Date:

02/03/2016

PCT Publication Date:

30/10/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

20/02/2019

EP B1 Publication Date:

20/02/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

25/04/2019

Expiration date:

25/04/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

13/02/2019

 

 

Name:

Seachaid Pharmaceuticals, Inc.

Address:

801 Capitola Drive Suite 5, Durham, NC 27713, United States (US)

Inventor

1

Name:

RADHAKRISHNAN, Balasingam

Address:

United States (US)

2

Name:

VAIDYA, Anuradha

Address:

United States (US)

Priority

Priority Number:

201361815932 P

Priority Date:

25/04/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/20; A61K 9/48; A61K 31/546; A61K 47/02; A61K 47/12; A61K 47/22; A61K 47/26; A61K 47/32; A61P 31/04; A61K 47/10; A61K 47/14; A61K 47/18;

Publication

European Patent Bulletin

Issue number:

201908

Publication date:

20/02/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages